Ernexa Therapeutics (ERNA) Assets Average (2016 - 2025)
Historic Assets Average for Ernexa Therapeutics (ERNA) over the last 15 years, with Q3 2025 value amounting to $6.9 million.
- Ernexa Therapeutics' Assets Average fell 7462.18% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 7462.18%. This contributed to the annual value of $27.2 million for FY2024, which is 2381.99% down from last year.
- According to the latest figures from Q3 2025, Ernexa Therapeutics' Assets Average is $6.9 million, which was down 7462.18% from $6.3 million recorded in Q2 2025.
- Over the past 5 years, Ernexa Therapeutics' Assets Average peaked at $52.1 million during Q3 2021, and registered a low of $5.2 million during Q1 2025.
- Moreover, its 5-year median value for Assets Average was $29.1 million (2023), whereas its average is $29.2 million.
- Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 16423.36% in 2024, then crashed by 8954.54% in 2025.
- Ernexa Therapeutics' Assets Average (Quarter) stood at $52.1 million in 2021, then tumbled by 58.5% to $21.6 million in 2022, then skyrocketed by 134.65% to $50.7 million in 2023, then plummeted by 87.19% to $6.5 million in 2024, then rose by 5.92% to $6.9 million in 2025.
- Its last three reported values are $6.9 million in Q3 2025, $6.3 million for Q2 2025, and $5.2 million during Q1 2025.